EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Prevalence and Clinical Associations of Vitamin D Deficiency in Inflammatory Bowel Disease: Evidence from a Tertiary Center Cohort

Theodora Kafentzi iD, Ploutarchos Pastras iD, Ioanna Aggeletopoulou iD, Efthymios P Tsounis iD, Georgios Geramoutsos iD, Nikitas Kimiskidis, Maria Bali, Konstantinos Thomopoulos, Georgia Diamantopoulou iD, Georgios Theocharis, Christos Triantos iD

Nutrients · 2025

DOI: 10.3390/nu17233698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Theodora Kafentzi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Vitamin D Deficiency, Inflammatory Bowel Diseases. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Vitamin D in its active form, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], plays a critical role in immune regulation, gut barrier function, and systemic inflammation. Its deficiency is frequent in Inflammatory Bowel Disease (IBD), but the clinical implications remain uncertain. The aim of the study is to assess the prevalence of vitamin D deficiency in a well-characterized IBD cohort in Western Greece, and explore its associations with clinical features, laboratory biomarkers, and treatment intensity.

Methods

In this cross-sectional study, 184 consecutive, well-characterized IBD outpatients followed at a tertiary referral center in Western Greece underwent clinical evaluation and laboratory testing between January 2023 and December 2024. Vitamin D is determined by measuring 25-hydroxyvitamin D [25(OH)D], which reflects the body’s vitamin D stores due to its longer half-life compared with the biologically active form. Deficiency was defined as serum 25(OH)D < 20 ng/mL. Associations with disease type, clinical and laboratory biomarkers, severity indices, and treatment were analyzed using multivariate logistic regression.

Results

Vitamin D deficiency was identified in 67 patients (36.4%). Although unrelated to disease type, hospitalization, surgery, or disease activity indices, deficiency correlated with systemic inflammation, nutrition/metabolic markers, and treatment intensity. More specifically, vitamin D-deficient patients exhibited higher platelet counts (p = 0.005) and erythrocyte sedimentation rate (ESR) (p = 0.014), lower hemoglobin (p = 0.005), albumin (p = 0.011), and serum glutamic-oxaloacetic transaminase (SGOT) (p = 0.009) levels and more frequent use of biologic therapy (p = 0.009). In multivariate analysis, vitamin D deficiency remained independently associated with biologic therapy (aOR = 0.374; 95% CI: 0.148–0.946), platelet count (aOR = 0.996, 95% CI: 0.992–0.999), and SGOT (aOR = 1.05, 95% CI: 1.00–1.10), indicating consistent links between vitamin D deficiency and treatment intensity, systemic inflammation, and nutritional or metabolic status.

Conclusions

Vitamin D deficiency is common among IBD patients and independently associates with systemic inflammation, metabolic impairment, and intensified treatment requirement, supporting its potential role as a marker of disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin D DeficiencyInflammatory Bowel DiseasesHumansMaleFemalePrevalenceCross-Sectional StudiesTertiary Care CentersAdultVitamin DMiddle AgedGreeceBiomarkersCohort Studies

Stichwörter der Autor:innen

SGOTbiologic therapyinflammatory bowel diseaseplateletssystemic inflammationvitamin D deficiency

Substanzen

Vitamin D25-hydroxyvitamin DBiomarkers

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, University of Patras, 26504 Patras, Greece.

ORCID-Profile: Theodora Kafentzi, Ploutarchos Pastras, Ioanna Aggeletopoulou, Efthymios P Tsounis, Georgios Geramoutsos, Georgia Diamantopoulou, Christos Triantos

Zitieren

APA

Kafentzi, T., Pastras, P., Aggeletopoulou, I., Tsounis, E. P., Geramoutsos, G., Kimiskidis, N., Bali, M., Thomopoulos, K., Diamantopoulou, G., Theocharis, G., & Triantos, C. (2025). High Prevalence and Clinical Associations of Vitamin D Deficiency in Inflammatory Bowel Disease: Evidence from a Tertiary Center Cohort. Nutrients. https://doi.org/10.3390/nu17233698

Vancouver

Kafentzi T, Pastras P, Aggeletopoulou I, Tsounis EP, Geramoutsos G, Kimiskidis N, et al. High Prevalence and Clinical Associations of Vitamin D Deficiency in Inflammatory Bowel Disease: Evidence from a Tertiary Center Cohort. Nutrients. 2025. doi:10.3390/nu17233698

BibTeX
@article{Kafentzi2025,
  author = {Kafentzi, Theodora and Pastras, Ploutarchos and Aggeletopoulou, Ioanna and Tsounis, Efthymios P and Geramoutsos, Georgios and Kimiskidis, Nikitas and Bali, Maria and Thomopoulos, Konstantinos and Diamantopoulou, Georgia and Theocharis, Georgios and Triantos, Christos},
  title = {High Prevalence and Clinical Associations of Vitamin D Deficiency in Inflammatory Bowel Disease: Evidence from a Tertiary Center Cohort},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17233698}
}
Kostenlos starten →